Authors: Keeffe, BG Valantine, H Keeffe, EB

Citation: Bg. Keeffe et al., Detection and treatment of coronary artery disease in liver transplant candidates, LIVER TRANS, 7(9), 2001, pp. 755-761

Authors: Moore, R Hernandez, D Valantine, H

Citation: R. Moore et al., Calcineurin inhibitors and post-transplant hyperlipidaemias, DRUG SAFETY, 24(10), 2001, pp. 755-766

Authors: Valantine, H Rickenbacker, P Kemna, M Hunt, S Chen, YDI Reaven, G Stinson, EB

Citation: H. Valantine et al., Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease - A prospective study, CIRCULATION, 103(17), 2001, pp. 2144-2152

Authors: Valantine, H

Citation: H. Valantine, Neoral use in the cardiac transplant recipient, TRANSPLAN P, 32(3A), 2000, pp. 27S-44S

Authors: Eisen, HJ Hobbs, RE Davis, SF Laufer, G Mancini, DM Renlund, DG Valantine, H Ventura, H Vachiery, JL Bourge, RC Canver, CC Carrier, M Costanzo, MR Copeland, J Dureau, G Frazier, OH Dorent, R Hauptman, PJ Kells, C Masters, R Michaud, JL Paradis, I Smith, A Vanhaecke, J Feutren, G Turkin, D Mellein, B Mueller, EA

Citation: Hj. Eisen et al., Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: A randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine - Results at six months after transplantation, TRANSPLANT, 68(5), 1999, pp. 663-671